Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Caribou Biosciences (CRBU) Shares Outstanding (Weighted Average): 2020-2024

Historic Shares Outstanding (Weighted Average) for Caribou Biosciences (CRBU) over the last 5 years, with Dec 2024 value amounting to $90.6 million.

  • Caribou Biosciences' Shares Outstanding (Weighted Average) rose 2.84% to $93.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $93.1 million, marking a year-over-year increase of 2.84%. This contributed to the annual value of $90.6 million for FY2024, which is 2.40% up from last year.
  • Caribou Biosciences' Shares Outstanding (Weighted Average) amounted to $90.6 million in FY2024, which was up 2.40% from $88.4 million recorded in FY2023.
  • In the past 5 years, Caribou Biosciences' Shares Outstanding (Weighted Average) registered a high of $90.6 million during FY2024, and its lowest value of $51.2 million during FY2020.
  • For the 3-year period, Caribou Biosciences' Shares Outstanding (Weighted Average) averaged around $80.1 million, with its median value being $88.4 million (2023).
  • Data for Caribou Biosciences' Shares Outstanding (Weighted Average) shows a peak YoY soared of 44.26% (in 2023) over the last 5 years.
  • Caribou Biosciences' Shares Outstanding (Weighted Average) (Yearly) stood at $51.2 million in 2020, then increased by 17.54% to $60.2 million in 2021, then climbed by 1.84% to $61.3 million in 2022, then skyrocketed by 44.26% to $88.4 million in 2023, then rose by 2.40% to $90.6 million in 2024.